Related Experiment Video
Updated: Jul 25, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
Update in postinfectious bronchiolitis obliterans
Alejandro Teper1, Alejandro J Colom1, Ralf Schubert2
1Respiratory Center, Hospital de Niños Dr. Ricardo Gutiérrez, Buenos Aires, Argentina.
Abstract:
Postinfectious bronchiolitis obliterans (PiBO) is a rare and severe form of chronic obstructive lung disease caused by an infectious injury to the lower respiratory tract. The most commonly recognized inciting stimuli leading to PiBO are airway pathogens, such as adenovirus and Mycoplasma. PiBO is characterized by persistent and nonreversible airway obstruction, with functional and radiological evidence of small airway involvement. The literature has limited information on the aetiology, clinical profile, treatment, and outcome of PiBO.
Insights
Postinfectious bronchiolitis obliterans (PiBO) is a severe lung disease from infection, causing irreversible airway obstruction. Further research is needed on its causes, symptoms, and treatment.
Area of Science:
- Pulmonology
- Infectious Diseases
- Pathology
Background:
- Postinfectious bronchiolitis obliterans (PiBO) is a rare but severe obstructive lung disease.
- It results from infectious injury to the lower respiratory tract, often by pathogens like adenovirus and Mycoplasma.
- PiBO leads to persistent, irreversible airway obstruction with small airway damage.
Purpose of the Study:
- To review the limited literature on PiBO.
- To consolidate information regarding the aetiology, clinical presentation, and management of PiBO.
- To highlight the need for further research into PiBO's outcomes.
Main Methods:
- Literature review of existing studies on PiBO.
- Synthesis of data on identified causes, clinical features, and treatments.
- Analysis of reported patient outcomes.
Main Results:
- Adenovirus and Mycoplasma are common triggers for PiBO.
- PiBO is characterized by functional and radiological signs of small airway disease.
- Significant gaps exist in understanding PiBO's full clinical spectrum and treatment efficacy.
Conclusions:
- PiBO represents a serious sequela of lower respiratory tract infections.
- Current knowledge on PiBO's aetiology, clinical course, and treatment is insufficient.
- More comprehensive studies are essential to improve the diagnosis and management of PiBO.
Related Concept Videos
Pneumonia II: Pathophysiology
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Cycle: Exhalation
Pneumonia III: Complications and Assessment

